Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sorbial is a French biotechnology company specializing in the development and production of microbial solutions, particularly probiotics for animal nutrition and health. Founded in 1989, the company established itself as a leader in the selection and stabilization of lactic acid bacteria strains for livestock applications. Sorbial was acquired by Lallemand Animal Nutrition in 2008, which allowed for the global expansion of its flagship probiotic products. The company's expertise lies in fermentation technology and the application of live microorganisms to improve gut health and feed efficiency. Its legacy continues through the widespread commercial use of strains like Pediococcus acidilactici in the poultry, swine, and aquaculture sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sorbial.